Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06892158 · ClinicalTrials.gov registry record · NA
Massage Impact on Sleep in Pediatric Oncology
A NA study of Cancer and Acute Myeloid Leukemia, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 2
- Study locations
NCT06892158: Recruiting NA study of Cancer and Acute Myeloid Leukemia, sponsored by Children's Hospital of Philadelphia.
NCT06892158 is a NA study of Cancer and Acute Myeloid Leukemia that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 70 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06892158, a NA study of Cancer and Acute Myeloid Leukemia, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).
Primary Outcome
Change in the total number of sleep minutes over time in the standard of care intervention compared to the change in the total number of sleep minutes over time in the massage therapy intervention. Sleep minutes are measured by actigraphy.
Conditions Studied
Interventions
- OTHER Standard of care
- OTHER Massage therapy
Study Locations (2)
District of Columbia
- Children's National Hospital - Washington D.C.
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2028-07 |
| Phase | NA |
What NCT06892158 shows while recruiting
NCT06892158 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower).
The record links to 6 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT06892158 reports a single indexed study location in District of Columbia, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06892158 about?
NCT06892158 is a clinical study titled "Massage Impact on Sleep in Pediatric Oncology". This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).
What is the current status of trial NCT06892158?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2025-01-23. Estimated completion is 2028-07.
What conditions does trial NCT06892158 study?
This clinical trial studies the following conditions: Cancer, Acute Myeloid Leukemia, Pediatric Cancer, Acute Lymphoblastic Leukemia, Pediatric, Chemotherapy Effect.
What interventions are being tested in trial NCT06892158?
The interventions under investigation include: Standard of care (OTHER), Massage therapy (OTHER).
Who is sponsoring clinical trial NCT06892158?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06892158 being conducted?
This trial has 2 study locations across District of Columbia, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06892158's enrollment target sits among peer trials
70 373rd of 615 higher than 236 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI